Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
about
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@en
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@nl
type
label
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@en
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@nl
prefLabel
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@en
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@nl
P2860
P356
P1476
Campath, calcineurin inhibitor ...... zed controlled clinical trial.
@en
P2093
3C Study Collaborative Group
P2860
P304
P356
10.1111/AJT.14619
P407
P577
2018-01-09T00:00:00Z